Dimethyl Fumarate: A Review in Relapsing-Remitting MS-Reference-Cited by-同舟云学术

Dimethyl Fumarate: A Review in Relapsing-Remitting MS

Published:2015-12-21 Issue:2 Volume:76 Page:243-254
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Deeks Emma D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-015-0528-1.pdf

Reference92 articles.

1. National Institute of Neurological Disorders and Stroke. Multiple sclerosis: hope through research. 2015. http://www.ninds.nih.gov/disorders/multiple_sclerosis/detail_multiple_sclerosis.htm . Accessed 3 Dec 2015.

2. National Multiple Sclerosis Society. What is MS? 2015. http://www.nationalmssociety.org . Accessed 3 Dec 2015.

3. Ortiz GG, Pacheco-Moises FP, Bitzer-Quintero OK, et al. Immunology and oxidative stress in multiple sclerosis: clinical and basic approach. Clin Dev Immunol. 2013;2013:708659.

4. Kim W, Zandona ME, Kim SH, et al. Oral disease-modifying therapies for multiple sclerosis. J Clin Neurol. 2015;11(1):9–19.

5. Gajofatto A, Benedetti MD. Treatment strategies for multiple sclerosis: when to start, when to change, when to stop? World J Clin Cases. 2015;3(7):545–55.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel Gastroprotective and Thermostable Cocrystal of Dimethyl Fumarate: Its Preparation, Characterization, and In Vitro and In Vivo Evaluation;ACS Omega;2023-07-11

2. The Diversity of Astrocyte Activation during Multiple Sclerosis: Potential Cellular Targets for Novel Disease Modifying Therapeutics;Healthcare;2023-05-29

3. Alopecia associated with dimethyl fumarate treatment for multiple sclerosis;Wiener Medizinische Wochenschrift;2023-03-15

4. Diroximel Fumarate as a Novel Oral Immunomodulating Therapy for Relapsing Forms of Multiple Sclerosis: A Review on the Emerging Data;Drug Design, Development and Therapy;2022-11

5. A cell-mimicking platelet-based drug delivery system as a potential carrier of dimethyl fumarate for multiple sclerosis;International Journal of Pharmaceutics;2022-09